• Benchmark index falls to 11-month lows
  • Utilities only sector in green
  • Small caps led by Noxopharm

 

Local markets have extended unexpected October losses on Wednesday as tech stocks, and the Financial Sector led losses on another bond-yield-led rout on Wall Street overnight.

At 4.15pm in Sydney, the ASX200 was down almost 0.8% to 6,890.20.

Over the past five days, the benchmark has lost -2% and is now down -2.85% over the past 12 months.

Wall Street was gripped by a sell-off overnight as stronger-than-expected US jobs data sent Treasury yields back up to the ionosphere. The benchmark YS 10-year US yield surged above 4.8% for the first time since 2007.

Regional equity markets also extended losses on Wednesday, as shares in Japan, South Korea and Hong Kong all fell sharply, many to multi-month lows.

Markets in China remain shut for a week-long holiday.

The ASX Small Ords lost 0.8% and the ASX Emerging Co’s (XEC) index lost 2.2%.

 

 ASX by Sectors on today   —  Intraday   —   52 Week Range  —  Week – Month – Year

Via MarketIndex

Ripped from the headlines

Japan

In Japan, the yen has steadied near 149 per USD on Wednesday arvo, after an unexpected surge late Tuesday raised fears that someone might need to go and intervene again in the local currency markets.

The currency jumped as much as 1.7% to 147.3,  before giving back most of the gains as stronger-than-expected US jobs data bolstered the view that the Federal Reserve will keep interest rates at restrictive levels for longer. Japan’s currency is like an old smoker’s heart and not good with shocks.

South China Sea

Philippines President Ferdinand Marcos Junior says investigations are ongoing around the deaths of three Filipino fishermen, in a ramming incident that sank their boat in the hotly contested waters of the South China Sea. Tensions between China and local Filipino fisherman have been ramping over months.

The ‘maritime incident’ occurred just as 1,800 soldiers, sailors and participants from the US – the Philippines’ former treaty ally – as well as strategic partners including Australia, Japan, Britain and Canada began to take part in ‘Samasama’ drills, which are set to last two weeks and include anti-submarine warfare, search and rescue operations, air defence drills and land phases.

“We assure the victims, their families, and everyone that we will exert every effort to hold accountable those who are responsible for this unfortunate maritime incident,” Ferdinand Marcos Junior said on the X social media platform.

Hong Kong

Stocks in Hong Kong were down over 1% in afternoon trade, sliding quickly for a second session while moving closer to their lowest level in over 11 months.

Hang Seng investors are on the coalface of China’s weak economic recovery and Beijing’s property market paralysis.

New data suggests China’s 100 biggest developers were still struggling to recover from deteriorating demand, with China Evergrande Group shares back amid double-digit losses on fears that the bankrupt giant could face liquidation while its founder and Chairman remains in detention.

 

TODAY’S ASX SMALL CAP LEADERS

Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Code Company Price % Volume Market Cap
CCE Carnegie Cln Energy 0.002 100% 547,211 $15,642,574
NOX Noxopharm Limited 0.105 69% 22,213,354 $18,118,753
BP8 Bph Global Ltd 0.002 33% 1,753,117 $2,002,095
NZS New Zealand Coastal 0.002 33% 6,038,171 $2,500,515
SIH Sihayo Gold Limited 0.002 33% 245,250 $18,306,384
YPB YPB Group Ltd 0.004 33% 205,415 $2,230,384
ADA Adacel Technologies 0.735 30% 363,704 $43,067,119
ICR Intelicare Holdings 0.015 25% 196,000 $2,506,985
TI1 Tombador Iron 0.015 25% 3,259,806 $25,901,788
ERL Empire Resources 0.005 25% 1,465,113 $4,451,740
BNR Bulletin Res Ltd 0.098 24% 4,940,429 $23,193,697
JPR Jupiter Energy 0.022 22% 19,000 $22,865,945
NIM Nimyresourceslimited 0.265 20% 700,943 $17,042,884
SCT Scout Security Ltd 0.018 20% 742,500 $3,460,020
ROO Roots Sustainable 0.006 20% 31,285,152 $693,611
VTI Vision Tech Inc 0.365 20% 156,258 $9,673,752
ICE Icetana Limited 0.039 18% 440,879 $8,156,181
TSL Titanium Sands Ltd 0.007 17% 2,204,193 $10,630,828
TGM Theta Gold Mines Ltd 0.145 16% 16,455 $88,134,376
MKG Mako Gold 0.015 15% 103,397 $7,488,106
AZI Altamin Limited 0.069 15% 732,233 $23,503,005
AL8 Alderan Resource Ltd 0.016 14% 17,343,515 $8,633,725
ETR Entyr Limited 0.008 14% 2,565,673 $13,881,727
OAU Ora Gold Limited 0.008 14% 182,115 $33,469,980
ABE Ausbondexchange 0.13 13% 15,137 $4,456,607
Wordpress Table Plugin

Noxopharm (ASX:NOX) is almost 70% higher at the close on Wednesday.

That’s not bad, after being caught speeding  the session previous by the ASX police.

The Aussie biotech has today shared the news that the US Food and Drug Administration has granted Orphan Drug Designation (ODD) status to Noxopharm’s CRO-67 preclinical drug candidate, for the treatment of pancreatic cancer.

The FDA grants ODDs for drugs designed to prevent, diagnose or treat rare diseases or conditions, and the designation comes with various benefits that include:

– Tax credits for qualified clinical trials
– Exemption from user fees (e.g. FDA application fees)
– Potential seven years of market exclusivity after approval

So far this year only x2 other Aussie companies have received an ODD from the FDA, from a total of 260 issued.

Another standout on Wednesday is the Aussie global space safety firm Adacel Technologies (ASX:ADA), which just won a new contact from the US Federal Aviation Administration (FAA) contract.

ADA says it’s a bit of an industry leader in ‘advanced air traffic management solutions and simulation and training systems, is looking at a terrific. US$59 million deal over five years, in a deal which covers services connected with ADA’s existing installed network of Tower Simulation Systems (TSS), ‘including the maintenance and support of the TSS hardware and a full-scale technical refresh for all major components within the TSS large and small systems and TSS Mobile Units.’

Daniel Verret, Adacel’s CEO says that Adacel brings ‘unique knowledge and unparalleled experience’ with the FAA TSS software systems.

We are steadfastly committed to making robust, consistent training a daily reality at the FAA,”  Mr. Verret added.

Lithium-junior Bulletin Resources (ASX:BNR) is up more than 25% today on news that it’s all but got its EPA approvals to begin drilling at its Ravensthorpe lithium project in WA’s Great Southern region.

And Redstone Resources (ASX:RDS) has revealed it’s partnering with Galan Lithium (ASX:GLN) ‘to further solidify its exposure to the highly sought after, Tier‐1 mining jurisdiction, that is the James Bay Lithium district in Québec, Canada.’

Earlier today my mentor in rocks, Reuben Adams said AZI is hoping to follow in the footsteps of much bigger brother Vulcan Energy (ASX:VUL) by producing both lithium and geothermal energy from deep brines.

“AZI – which has been focused on getting its Gorno zinc project up and running – picked up a couple of geothermal energy-lithium brines applications in Lazio, Italy, June last year.

“The stock has now expanded its tenure by 500% after an independent consultant said there was def potential for both power production and lithium extraction at Lazio,” Reubs added.

“Preliminary discussions are being held with potential strategic partners, European funds and financial institutions to explore options to advance the Lazio project,” AZI says.

“Altamin is also considering the possibility of a future ‘spin off’ of the assets into a new lithium focused company once key project milestones have been achieved.”

The $30m capped company had $1m in the bank at the end of June.

 

High grade iron ore producer Tomador Iron (TI1) has recovered slightly from yesterday’s precipitous fall, but the news still ain’t good.

A previously announced “geotechnical event” at its namesake mine in Brazil is a bit worse than originally thought, with work to make the mine safe leading to constrained production in the September quarter of ~112,000 wet metric tonnes.

TI1 expects production constraints – and subsequent higher costs – to continue during the December 2023 quarter as it awaits “further geotechnical advice”.

The silver lining is that sales levels have exceeded production in the quarter by utilising stockpiled product.

 

TODAY’S ASX SMALL CAP LAGGARDS

Here are the best performing ASX small cap stocks:

Swipe or scroll to reveal full table. Click headings to sort:

Code Company Price % Volume Market Cap
TKM Trek Metals Ltd 0.034 -36% 14,749,866 $26,188,364
GTG Genetic Technologies 0.002 -33% 2,182,691 $34,624,974
MTL Mantle Minerals Ltd 0.002 -33% 111,041 $18,442,338
RBR RBR Group Ltd 0.002 -33% 1,300,062 $4,855,214
ERG Eneco Refresh Ltd 0.016 -27% 165,010 $5,991,884
MRD Mount Ridley Mines 0.0015 -25% 1,052,334 $15,569,766
AGD Austral Gold 0.022 -24% 6,555 $17,757,029
STA Strandline Res Ltd 0.085 -23% 23,495,877 $160,882,066
FFF Forbidden Foods 0.014 -22% 1,717,038 $3,363,490
RAS Ragusa Minerals Ltd 0.03 -21% 690,178 $5,418,754
CUF Cufe Ltd 0.012 -20% 3,231,123 $17,191,685
CYQ Cycliq Group Ltd 0.004 -20% 141,250 $1,787,583
SI6 SI6 Metals Limited 0.0065 -19% 19,660,629 $15,950,875
DY6 Dy6Metalsltd 0.11 -19% 70,636 $5,205,936
TAL Talius Group Limited 0.009 -18% 1,145,087 $25,147,533
WNR Wingara Ag Ltd 0.028 -18% 32,003 $5,968,445
KCC Kincora Copper 0.03 -17% 100,000 $5,773,646
EDE Eden Inv Ltd 0.0025 -17% 403,109 $10,090,911
ROG Red Sky Energy. 0.005 -17% 1,181,119 $31,813,363
MGA Metalsgrovemining 0.105 -16% 5,171 $4,650,063
BIT Biotron Limited 0.076 -16% 16,645,768 $81,175,041
FTC Fintech Chain Ltd 0.011 -15% 18,000 $8,460,005
LPM Lithium Plus 0.475 -15% 1,935,628 $36,953,392
EME Energy Metals Ltd 0.17 -15% 61,517 $41,936,662
C1X Cosmosexploration 0.285 -15% 327,631 $14,899,125
Wordpress Table Plugin

 

TRADING HALTS

Accelerate Resources (ASX:AX8) – Pending an announcement in regarding a potential material acquisition and associated capital raising

Cauldron Energy (ASX:CXU) – Pending an announcement by the Company regarding a material capital raising

Neurotech (ASX:NTI) – Pending the release of the results of the Company’s Phase I/II clinical trial in paediatric patients with PANDAS/PANS

Dimerix (ASX:DXB) – Pending the release of an announcement regarding a licensing agreement.